Internal medicine journal, 2014-12, Vol.44 (12b), p.1350-1363
2014
Details
- Autor(en) / Beteiligte
- Titel
- Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014
- Ist Teil von
- Internal medicine journal, 2014-12, Vol.44 (12b), p.1350-1363
- Ort / Verlag
- Australia: Blackwell Publishing Ltd
- Erscheinungsjahr
- 2014
- Link zum Volltext
- Quelle
- Wiley Online Library Journals Frontfile Complete
- Beschreibungen/Notizen
- Pneumocystis jirovecii infection (PJP) is a common cause of pneumonia in patients with cancer‐related immunosuppression. There are well‐defined patients who are at risk of PJP due to the status of their underlying malignancy, treatment‐related immunosuppression and/or concomitant use of corticosteroids. Prophylaxis is highly effective and should be given to all patients at moderate to high risk of PJP. Trimethoprim‐sulfamethoxazole is the drug of choice for prophylaxis and treatment, although several alternative agents are available.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1444-0903eISSN: 1445-5994DOI: 10.1111/imj.12599Titel-ID: cdi_proquest_miscellaneous_1634727031
- Format
- –
- Schlagworte
- Adrenal Cortex Hormones - administration & dosage, Adrenal Cortex Hormones - adverse effects, Antibiotic Prophylaxis, Consensus, Drug Administration Schedule, haematological malignancy, Humans, Immunocompromised Host - immunology, Neoplasms - complications, Neoplasms - immunology, Opportunistic Infections - immunology, Opportunistic Infections - microbiology, Opportunistic Infections - prevention & control, Pneumocystis carinii, Pneumocystis carinii - pathogenicity, Pneumocystis jirovecii, Pneumonia, Pneumocystis - immunology, Pneumonia, Pneumocystis - microbiology, Pneumonia, Pneumocystis - prevention & control, Practice Guidelines as Topic, prophylaxis, solid-organ tumour, treatment, Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage